Tingbo Ding

579 total citations
22 papers, 472 citations indexed

About

Tingbo Ding is a scholar working on Molecular Biology, Cell Biology and Physiology. According to data from OpenAlex, Tingbo Ding has authored 22 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Cell Biology and 6 papers in Physiology. Recurrent topics in Tingbo Ding's work include Sphingolipid Metabolism and Signaling (13 papers), Lipid Membrane Structure and Behavior (6 papers) and Lipid metabolism and biosynthesis (6 papers). Tingbo Ding is often cited by papers focused on Sphingolipid Metabolism and Signaling (13 papers), Lipid Membrane Structure and Behavior (6 papers) and Lipid metabolism and biosynthesis (6 papers). Tingbo Ding collaborates with scholars based in China, United States and South Korea. Tingbo Ding's co-authors include Xian‐Cheng Jiang, Jibin Dong, Ming‐Shang Kuo, Zhiqiang Li, Guoqing Cao, Bin Lou, Hui Jiang, Hai H. Bui, Zhiqiang Li and Yue Li and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and PLoS ONE.

In The Last Decade

Tingbo Ding

22 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tingbo Ding China 12 353 108 86 82 78 22 472
Ainara G. Cabodevilla United States 7 232 0.7× 86 0.8× 59 0.7× 84 1.0× 124 1.6× 14 492
Tan Hooi Min Grahn Sweden 10 272 0.8× 155 1.4× 51 0.6× 152 1.9× 73 0.9× 17 494
Ju-Qiong Wang China 8 244 0.7× 65 0.6× 88 1.0× 37 0.5× 103 1.3× 8 513
Baasanjav Uranbileg Japan 16 393 1.1× 101 0.9× 132 1.5× 32 0.4× 77 1.0× 29 499
Yasunori Tokuhara Japan 12 267 0.8× 69 0.6× 94 1.1× 37 0.5× 47 0.6× 25 393
Anna Abella France 8 402 1.1× 142 1.3× 80 0.9× 134 1.6× 67 0.9× 8 535
Kazuki Moro Japan 11 300 0.8× 56 0.5× 86 1.0× 27 0.3× 36 0.5× 27 483
Charlie Marvalim Singapore 6 237 0.7× 47 0.4× 50 0.6× 38 0.5× 67 0.9× 8 383
Moua Yang United States 13 263 0.7× 33 0.3× 42 0.5× 70 0.9× 49 0.6× 34 527

Countries citing papers authored by Tingbo Ding

Since Specialization
Citations

This map shows the geographic impact of Tingbo Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tingbo Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tingbo Ding more than expected).

Fields of papers citing papers by Tingbo Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tingbo Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tingbo Ding. The network helps show where Tingbo Ding may publish in the future.

Co-authorship network of co-authors of Tingbo Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Tingbo Ding. A scholar is included among the top collaborators of Tingbo Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tingbo Ding. Tingbo Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guang, Liu, Ziyi Wu, Qingyuan Yang, et al.. (2025). CD63-Mediated SARS-CoV-2 RBD Fusion Neoantigen DNA Vaccine Enhances Antitumor Immune Response in a Mouse Panc02 Model via EV-Targeted Delivery. Vaccines. 13(9). 977–977. 1 indexed citations
2.
Jiang, Xin, et al.. (2024). SMS2 siRNA inhibits pancreatic tumor growth by tumor microenvironment modulation. International Immunopharmacology. 142(Pt A). 113111–113111. 1 indexed citations
3.
He, Shuhua, Xiang Gu, Jintong Yang, et al.. (2022). Sphingomyelin synthase 2 is a positive regulator of the CSF1R-STAT3 pathway in pancreatic cancer-associated macrophage. Frontiers in Pharmacology. 13. 902016–902016. 7 indexed citations
4.
Deng, Yan, Shuhua He, Bin Lou, et al.. (2020). Sphingomyelin synthase 2 facilitates M2-like macrophage polarization and tumor progression in a mouse model of triple-negative breast cancer. Acta Pharmacologica Sinica. 42(1). 149–159. 39 indexed citations
5.
Zhang, Qing, Qi Liu, Jibin Dong, et al.. (2019). A novel assay for measuring recombinant human lysophosphatidylcholine acyltransferase 3 activity. FEBS Open Bio. 9(10). 1734–1743. 2 indexed citations
6.
Lou, Bin, Qi Liu, Jiahui Hou, et al.. (2018). 2-Hydroxy-oleic acid does not activate sphingomyelin synthase activity. Journal of Biological Chemistry. 293(47). 18328–18336. 10 indexed citations
7.
Li, Yali, Bin Lou, Deyong Ye, et al.. (2018). Discovery, synthesis and anti-atherosclerotic activities of a novel selective sphingomyelin synthase 2 inhibitor. European Journal of Medicinal Chemistry. 163. 864–882. 23 indexed citations
8.
Lou, Bin, Jibin Dong, Zhiqiang Li, et al.. (2018). Lysophosphatidylcholine acyltransferase 3 deficiency impairs 3T3L1 cell adipogenesis through activating Wnt/β-catenin pathway. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1863(8). 834–843. 11 indexed citations
9.
Liu, Huijuan, Xiaoxiao Jiang, Yizhen Guo, et al.. (2017). The flavonoid TL-2-8 induces cell death and immature mitophagy in breast cancer cells via abrogating the function of the AHA1/Hsp90 complex. Acta Pharmacologica Sinica. 38(10). 1381–1393. 34 indexed citations
10.
Ding, Tingbo, Inamul Kabir, Yue Li, et al.. (2015). All members in the sphingomyelin synthase gene family have ceramide phosphoethanolamine synthase activity. Journal of Lipid Research. 56(3). 537–545. 33 indexed citations
11.
Li, Zhiqiang, Hui Jiang, Tingbo Ding, et al.. (2015). Deficiency in Lysophosphatidylcholine Acyltransferase 3 Reduces Plasma Levels of Lipids by Reducing Lipid Absorption in Mice. Gastroenterology. 149(6). 1519–1529. 69 indexed citations
12.
Li, Yali, Hui Jiang, Yanping Dong, et al.. (2015). Discovery, synthesis and biological evaluation of 2-(4-(N-phenethylsulfamoyl)phenoxy)acetamides (SAPAs) as novel sphingomyelin synthase 1 inhibitors. Bioorganic & Medicinal Chemistry. 23(18). 6173–6184. 15 indexed citations
14.
Ding, Tingbo & Xian‐Cheng Jiang. (2014). Sphingomyelin synthase activity measurement by the fluorescent product in cell culture medium or animal plasma. Journal of Chinese Pharmaceutical Sciences. 23(4). 1 indexed citations
15.
Fu, Lin, Ya Zhang, Yan Li, et al.. (2013). Identification of small molecule sphingomyelin synthase inhibitors. European Journal of Medicinal Chemistry. 73. 1–7. 30 indexed citations
16.
Li, Yue, Jibin Dong, Tingbo Ding, et al.. (2013). Sphingomyelin Synthase 2 Activity and Liver Steatosis. Arteriosclerosis Thrombosis and Vascular Biology. 33(7). 1513–1520. 59 indexed citations
18.
Ding, Tingbo, et al.. (2011). Sphingomyelin synthase overexpression increases cholesterol accumulation and decreases cholesterol secretion in liver cells. Lipids in Health and Disease. 10(1). 46–46. 24 indexed citations
19.
Yeang, Calvin, Tingbo Ding, William J. Chirico, & Xian‐Cheng Jiang. (2011). Subcellular Targeting Domains of Sphingomyelin Synthase 1 and 2. Nutrition & Metabolism. 8(1). 89–89. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026